CLINICAL TRIALS PROFILE FOR VANCERIL
✉ Email this page to a colleague
All Clinical Trials for VANCERIL
| Trial ID | Title | Status | Sponsor | Phase | Start Date | Summary |
|---|---|---|---|---|---|---|
| NCT00489203 ↗ | Beclomethasone Dipropionate in Preventing Acute Graft-Versus-Host Disease in Patients Undergoing a Donor Stem Cell Transplant for Hematologic Cancer | Completed | Fred Hutchinson Cancer Research Center | Phase 2 | 2007-04-01 | RATIONALE: Beclomethasone dipropionate may be effective in preventing acute graft-versus-host disease in patients undergoing a stem cell transplant for hematologic cancer. PURPOSE: This randomized phase II trial is studying how well beclomethasone dipropionate works in preventing acute graft-versus-host disease in patients undergoing a donor stem cell transplant for hematologic cancer. |
| >Trial ID | >Title | >Status | >Sponsor | >Phase | >Start Date | >Summary |
Clinical Trial Conditions for VANCERIL
Condition Name
| Condition Name for VANCERIL | |
| Intervention | Trials |
| Refractory Chronic Lymphocytic Leukemia | 1 |
| Blastic Phase Chronic Myelogenous Leukemia | 1 |
| Stage III Adult Diffuse Small Cleaved Cell Lymphoma | 1 |
| Noncontiguous Stage II Adult Burkitt Lymphoma | 1 |
| [disabled in preview] | 0 |
| This preview shows a limited data set Subscribe for full access, or try a Trial | |
Condition MeSH
| Condition MeSH for VANCERIL | |
| Intervention | Trials |
| Lymphoma, B-Cell, Marginal Zone | 1 |
| Leukemia, Myelogenous, Chronic, BCR-ABL Positive | 1 |
| Precursor Cell Lymphoblastic Leukemia-Lymphoma | 1 |
| Lymphoma, Non-Hodgkin | 1 |
| [disabled in preview] | 0 |
| This preview shows a limited data set Subscribe for full access, or try a Trial | |
Clinical Trial Locations for VANCERIL
Trials by Country
Clinical Trial Progress for VANCERIL
Clinical Trial Phase
Clinical Trial Sponsors for VANCERIL
Sponsor Name
